Nachrichten zur GSK PLC Aktie

GSK plc (GSK) Q4 2023 Earnings Call Transcript

…

ROUNDUP: Pharmahersteller GSK will auch 2024 mehr verdienen - Aktie legt zu

LONDON (dpa-AFX) - Der Pharmakonzern GSK rechnet nach einem Ergebnis- und Umsatzplus im vergangenen Jahr…

GSK plc 2023 Q4 - Results - Earnings Call Presentation

…

Pharmahersteller GSK will auch 2024 mehr verdienen - optimistischer für Zukunft

LONDON (dpa-AFX) - Der Pharmakonzern GSK rechnet nach einem Ergebnis- und Umsatzplus im vergangenen Jahr…

GSK: Im Norden nichts Neues - Aktienanalyse

Wien (www.aktiencheck.de) - GSK-Aktienanalyse von der Raiffeisen Bank International AG: Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI), nimmt die…

GSK, Novo Nordisk, interest rates and Boeing: Day Ahead on Wednesday

Followers of big pharma are likely to be keen to hear from GSK PLC (LSE:GSK, NYSE:GSK) and Novo Nordisk (NYSE:NVO) on Wednesday, while…

GSK, Novo Nordisk, interest rates and Boeing: Day Ahead on Wednesday

Followers of big pharma are likely to be keen to hear from GSK PLC (LSE:GSK, NYSE:GSK) and Novo Nordisk (NYSE:NVO) on Wednesday, while…

GSK RSV vaccine achieves blockbuster status in just over six months

GSK PLC has seen its RSV vaccines shoot to blockbuster status in little over six months, according to the Financial Times…

GSK: Coverage aufgenommen

New York (www.aktiencheck.de) - Rating-Update: Mark Purcell, Analyst von Morgan Stanley, nimmt die Coverage der Aktie von GSK plc. (ISIN: GB00BN7SWP63,…

GSK nets £978m from Haleon share sale

GSK PLC (LSE:GSK, NYSE:GSK) said it completed the sale of 300 million shares in Haleon, the consumer health giant, netting…

GSK and AstraZeneca: an upgrade and a downgrade from this investment bank

UBS has revised its stance on two major UK-listed pharma companies – GSK PLC (LSE:GSK, NYSE:GSK) and AstraZeneca PLC (LSE:AZN) – with…

GSK and AstraZeneca: an upgrade and a downgrade from this investment bank

UBS has revised its stance on two major UK-listed pharma companies – GSK PLC (LSE:GSK, NYSE:GSK) and AstraZeneca PLC (LSE:AZN) – with…

Is GSK worth £20 a share? This broker seems to thinks so

Shore Capitals recent research note on GSK PLC (LSE:GSK, NYSE:GSK) paints an optimistic picture for the pharmaceutical giant, underlining reasons…

GSK plc (GSK) 42nd Annual JP Morgan Healthcare Conference (Transcript)

…

GSK: Eine beeindruckende Performance - Die Aktie bleibt ein Value-Pick - Aktienanalyse

Wien (www.aktiencheck.de) - GSK-Aktienanalyse von der Raiffeisen Bank International AG: Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI), rät in…

GSK strong finish expected, says Barclays

GSK PLC (LSE:GSK, NYSE:GSK) should deliver better than expected fourth-quarter results on January 31, according to Barclays, amid heightened expectations...…

GSK to pay up to $1.4bn for respiratory acquisition

GSK PLC (LSE:GSK, NYSE:GSK) has moved to bolster its respiratory franching with the acquisition of Aiolos Bio for up to $1.4bn.…

GSK to pay up to US$1.4bn for respiratory acquisition

GSK PLC (LSE:GSK, NYSE:GSK) has moved to bolster its respiratory pipeline with the acquisition of Aiolos Bio for up to US$1.4 billion.…

GSK gets shot in arm from upgrade, AstraZeneca mixed reviews after China deal

GSK PLC (LSE:GSK, NYSE:GSK) shares got a shot in the arm this morning after Jefferies took a more positive view of…

ANALYSE-FLASH: Jefferies hebt GSK auf 'Buy' und Ziel auf 1900 Pence

NEW YORK (dpa-AFX) - Das Analysehaus Jefferies hat GSK von "Hold" auf "Buy" hochgestuft und…

ANALYSE-FLASH: Jefferies hebt GSK auf 'Buy' und Ziel auf 1900 Pence

NEW YORK (dpa-AFX) - Das Analysehaus Jefferies hat GSK von "Hold" auf "Buy" hochgestuft und…

GSK drug combination significantly improves survival in women with a hard-to-treat form of endometrial cancer

GSK PLC (LSE:GSK, NYSE:GSK) said its cancer immuno-therapy Jemperli had shown promise when used in harness with an existing cancer drug Zejula…

GSK get European green light for endometrial cancer treatment

GSK PLC (LSE:GSK, NYSE:GSK) said the European Commission had granted marketing authorization for Jemperli (dostarlimab) in combination with chemotherapy for...…

GSK plc (GSK) Getting Ahead of Respiratory Diseases Event with GSK Management Conference (Transcript)

…

GSK plc (GSK) Presents at Redburn Atlantic CEO Conference (Transcript)

…

GSK plc (GSK) Presents at 6th Annual Evercore ISI HealthCONx Conference (Transcript)

…

GSK: Drittes Quartal zufriedenstellend - Sorgen um die Zantac-Causa überwiegen im Markt - Aktienanalyse

Wien (www.aktiencheck.de) - GSK-Aktienanalyse von der Raiffeisen Bank International AG: Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI), rät in…

GSK myeloma drug shows promise in hard-to-treat patient group

In a significant development for patients battling multiple myeloma, a type of blood cancer, GSK PLC (LSE:GSK, NYSE:GSK) has announced…

ANALYSE-FLASH: Jefferies senkt Ziel für GSK auf 1550 Pence - 'Hold'

NEW YORK (dpa-AFX Broker) - Das Analysehaus Jefferies hat das Kursziel für GSK von 1650…

GSK receives EU regulatory boost for bone marrow cancer drug

GSK PLC (LSE:GSK, NYSE:GSK) has received a positive recommendation from the European Medicines Agencys Committee for Medicinal Products for Human…

GSK receives EU regualtory boost for bone marrow cancer drug

GSK PLC (LSE:GSK, NYSE:GSK) has received a positive recommendation from the European Medicines Agencys Committee for Medicinal Products for Human…

GSK falls victim to ‘hard to please’ pharma market

GSK PLC (LSE:GSK, NYSE:GSK)’s seemingly positive earnings release on Wednesday has been labelled as just that by Stifel analysts, who…

ANALYSE-FLASH: JPMorgan hebt Ziel für GSK auf 1400 Pence - 'Underweight'

NEW YORK (dpa-AFX Broker) - Die US-Bank JPMorgan hat das Kursziel für GSK nach Zahlen…

GSK plc (GSK) Q3 2023 Earnings Call Transcript

…

GSK receives a mixed City reaction despite raised outlook

GSK PLC (LSE:GSK, NYSE:GSK) has received mixed reactions from City analysts despite an objectively strong third-quarter performance and raised financial...…

GSK receives a mixed City reaction despite raised outlook

GSK PLC (LSE:GSK, NYSE:GSK) has received mixed reactions from City analysts despite an objectively strong third-quarter performance and raised financial...…

ROUNDUP: Pharmakonzern GSK hebt erneut Ziele an - Aktie mit Gewinnmitnahmen

LONDON (dpa-AFX) - Der Pharmakonzern GSK hat seinen guten Lauf mit einem weiteren überraschend starken…

GSK plc 2023 Q3 - Results - Earnings Call Presentation

…

RSV-Impfung läuft stark: Pharmahersteller GSK hebt erneut Ziele an

LONDON (dpa-AFX) - Der Pharmakonzern GSK hat seinen guten Lauf mit einem weiteren überraschend starken…

GSK raises outlook amid strong demand for new RSV vaccine

GSK PLC (LSE:GSK, NYSE:GSK) said a strong third-quarter performance has driven a further upgrade to full-year guidance boosted by demand…

TAGESVORSCHAU/Mittwoch, 1. November

DJ TAGESVORSCHAU/Mittwoch, 1. November === *** 08:00 GB/GSK plc, Ergebnis 3Q 09:30 GB/Aston Martin Lagonda Global Holdings plc, Ergebnis 3Q…

GSK, Aston Martin, Next and more: Day Ahead on Wednesday

For no obvious reason, GSK PLC (LSE:GSK, NYSE:GSK) shares fell to a six-week low ahead of its third-quarter results, giving up gains…

GSK, Aston Martin, Next and more: Day Ahead on Wednesday

For no obvious reason, GSK PLC (LSE:GSK, NYSE:GSK) shares fell to a six-week low ahead of its third-quarter results, giving up gains…

Oncology Active Pharmaceutical Ingredient (API) Market revenue to reach USD 7 Billion by 2035, says Research Nester

Leading Oncology Active Pharmaceutical Ingredient (API) Market players include Sanofi, AbbVie Inc., Merck & Co. Inc., Pfizer Inc., Abbott Laboratories,…

Form 6-K GSK plc For: Aug 25

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

China vaccine test provide a shot in the arm for Glaxo boss

The FTSE 100 firms blockbuster shingles vaccine shingrix was 100pc effective in a recent study in adults over the age…

Form 6-K GSK plc For: Aug 23

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

GSK gets positive results from shingles trial of Shingrix in China

Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…

GSK Plc Reports 100% Vaccine Efficacy From Post-license Phase IV Trial Of Shingrix In China

LONDON (dpa-AFX) - GSK plc (GSK, GSK.L) reported positive results from the efficacy trial of Shingrix in China. The results…

Form 6-K GSK plc For: Aug 22

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…